Although close collaboration with a variety of specialists outside of rheumatology is important, you could make the case for rheumatologists and pulmonologists having to work together even more closely. If lung symptoms are severe and not under control, the results could be fatal. However, the question sometimes is when to refer—even when there are not…
A case report
Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists
Relapses are common, but difficult to predict and prevent.
Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.
The role of HMGB1 in the pathogenesis of lupus nephritis
Delving deeper into the nonvasculitis aspects of the disease
Clinical trials show changing role of existing treatment and introduction of newer medications
Handpicked Reviews of Contemporary Literature
WG has an evolving prognosis and treatment course